<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02700516</url>
  </required_header>
  <id_info>
    <org_study_id>32364/200</org_study_id>
    <nct_id>NCT02700516</nct_id>
  </id_info>
  <brief_title>Recurrent Glomerulonephritis After Renal Transplantation</brief_title>
  <official_title>Recurrent Primary Glomerulonephritis After Renal Transplantation: Effects on Renal Allografts and Transplant Recipients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Istanbul University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Istanbul University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Glomerulonephritis (GN) is the leading cause of end-stage renal disease in 30% to 50% of
      patients who receive a renal transplant. The exact prevalence of either recurrent or de novo
      GN is unknown since a considerable number of patients never undergo allograft biopsy, leaving
      GN underdiagnosed. The aim of this study is to evaluate the effects of recurrent GN on the
      prevalence, risk factors, clinicopathological features, and outcome of renal transplant
      recipients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Glomerulonephritis is the leading cause of end-stage renal disease in 30% to 50% of patients
      who receive a renal transplant. Even though recurrent or de novo posttransplant primary GN is
      the third most frequent cause of renal allograft loss after renal transplantation, different
      recurrence rates have been reported in different patient series worldwide. With the
      implementation of diverse and improved immunosuppressive treatment regimens and prolongation
      of graft survival, renal allograft loss caused by recurrent or de novo GN will be more
      important than ever. Data obtained from comparing patients who have recurrent primary GN
      against patients with non-recurrent GN and renal transplant recipients with non-GN etiology
      shall bring new approaches to the daily practice of managing patients with GN and renal
      failure, assessing them as transplant candidates and applying new therapies.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2015</start_date>
  <completion_date type="Actual">April 2016</completion_date>
  <primary_completion_date type="Actual">March 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Allograft survival</measure>
    <time_frame>1 - 5 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Allograft rejection</measure>
    <time_frame>1 - 5 years</time_frame>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Actual">360</enrollment>
  <condition>Glomerulonephritis</condition>
  <arm_group>
    <arm_group_label>Recurrent GN</arm_group_label>
    <description>Renal transplant recipients with biopsy-confirmed recurrent primary glomerulonephritis.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non-recurrent GN</arm_group_label>
    <description>Renal transplant recipients with non-recurrent primary glomerulonephritis.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non-GN</arm_group_label>
    <description>Renal transplant recipients with etiologies other than primary glomerulonephritis.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Renal transplant recipients
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients who underwent a renal transplantation because of an end-stage renal disease
             caused by primary glomerulonephritis and have biopsy-proven recurrent primary
             glomerulonephritis (Recurrent GN group)

          -  Patients who underwent a renal transplantation because of an end-stage renal disease
             caused by primary glomerulonephritis and have no signs of recurrence (Non-recurrent GN
             group)

          -  Patients who underwent a renal transplantation because of an end-stage renal disease
             linked to an etiology other than primary glomerulonephritis (Non-GN group)

        Exclusion Criteria:

          -  Patients who are unwilling or unable to consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yasar Caliskan, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Division of Nephrology, Department of Internal Medicine, Istanbul Faculty of Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Division of Nephrology, Department of Internal Medicine, Istanbul Faculty of Medicine</name>
      <address>
        <city>Istanbul</city>
        <zip>34093</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Division of Nephrology, Department of Internal Medicine, Cerrahpasa Faculty of Medicine</name>
      <address>
        <city>Istanbul</city>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <reference>
    <citation>Briganti EM, Russ GR, McNeil JJ, Atkins RC, Chadban SJ. Risk of renal allograft loss from recurrent glomerulonephritis. N Engl J Med. 2002 Jul 11;347(2):103-9.</citation>
    <PMID>12110738</PMID>
  </reference>
  <verification_date>April 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 25, 2016</study_first_submitted>
  <study_first_submitted_qc>March 1, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 7, 2016</study_first_posted>
  <last_update_submitted>April 3, 2016</last_update_submitted>
  <last_update_submitted_qc>April 3, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 5, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Istanbul University</investigator_affiliation>
    <investigator_full_name>Yasar Caliskan</investigator_full_name>
    <investigator_title>Associate Professor of Medicine</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Glomerulonephritis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

